Library

867 Results

Sterile Injectables Contract Manufacturing

Sterile Injectables Contract Manufacturing

Baxter BioPharma Solutions | 02-Apr-2018 | Product Brochure

Baxter BioPharma Solutions' award-winning facility in Bloomington, Indiana, USA, is a leader in sterile contract manufacturing of injectable products.

lyo_development

Lyophilization Scale-Up and Tech Transfer

Baxter BioPharma Solutions | 12-Mar-2018 | Technical / White Paper

There are few challenges when increasing the scale of production for a solution formulation, but the challenges drastically increase when the formulation...

How will Brexit affect the Pharmaceutical Industry?

How will Brexit affect the Pharmaceutical Industry?

Source BioScience Ltd | 08-Mar-2018 | Technical / White Paper

Have you prepared your strategy for the outcome of Brexit to ensure that you can continue to supply the UK market?
Source BioScience is a CRO with...

Leveraging Best Practices in Primary Packaging

Leveraging Best Practices in Primary Packaging

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

When planning a clinical trial, overlooking the importance of primary packaging can be a mistake. From stability concerns to labeling to patient compliance...

Strategies to Select and Deliver the Right Candidate

Strategies to Select and Deliver the Right Candidate

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

Does your candidate have what it takes to succeed? Do you have the information needed to make the right decisions about your candidate’s path to the clinic?...

SQ-USP-Brochure-Thumb-AP-CC

NEW…sugarcane derived USP Squalane from Aprinnova

APRINNOVA – A joint venture of AMYRIS and NIKKOL Group | 26-Feb-2018 | Product Brochure

To date, topical formulation chemists have been restricted to using Squalane derived from the harvesting of shark livers. Neossance Squalane USP, derived...

Roquette Oral Dose Case Study - Part IV

Roquette Oral Dose Case Study - Part IV

Roquette Pharma Solutions | 04-Dec-2017 | Case Study

Download the latest Roquette case study and learn more on how PEARLITOL® Flash mannitol and starch compound offers inert stability, fast disintegration...

Roquette Oral Dose Case Study - Part III

Roquette Oral Dose Case Study - Part III

Roquette Pharma Solutions | 27-Nov-2017 | Case Study

Download the Case Study to find out how Roquette’s SweetPearl® P 300 DC maltitol technology makes an effervescent tablet solution attractive and palatable...

VDS groß

Meet the challenges of complex injectables

Vetter Pharma International GmbH | 07-Nov-2017 | Technical / White Paper

In the time it takes from the exciting discovery phase to the rigorous demands of a commercial launch, unexpected scientific and technical challenges can...

Roquette Oral Dose Case Study - Part I

Roquette Oral Dose Case Study - Part I

Roquette Pharma Solutions | 06-Nov-2017 | Case Study

Download the Case study and learn more on ReadiLYCOAT®: Immediate release film coating system for heat sensitive oral dosage forms is a breakthrough in...

Roquette Oral Dose Case Study - Part II

Roquette Oral Dose Case Study - Part II

Roquette Pharma Solutions | 06-Nov-2017 | Case Study

Download the case study and learn more on how Roquette’s taste masking technology KLEPTOSE® Linecaps (KL) allows the delivery of an efficient taste masking...

The Solid Dose, Latest News from Colorcon

The Solid Dose, Latest News from Colorcon

Colorcon Inc. | 06-Nov-2017 | Data Sheet

With a commitment to serve customers through product innovation and technical excellence, Colorcon's Solid Dose newsletter brings you the latest insight...

lyo_vials

Process Development for Lyophilized Products

Baxter BioPharma Solutions | 30-Oct-2017 | Application Note

Baxter approaches formulation and process development with the intention of identifying the failure points for the product. Knowing where the product fails...

Why managing variability?

Why managing variability?

SIO/ADM | 02-Oct-2017 | Research Study

Significant efforts are necessary to develop an active pharmaceutical ingredient (API). It is therefore risky to expose this API to poorly characterized...

Steridose

Optimizing vessel geometry for mag drive agitators

Steridose, Inc | 14-Sep-2017 | Technical / White Paper

The performance of a bottom mount magnetically driven agitator (mag drive mixer) is heavily dependent on its relationship with the vessel’s geometry, baffles,...

Ocopeptides

Advancing therapeutics for myeloma

Recipharm AB | 04-Sep-2017 | Case Study

Multiple myeloma is the second most common blood cancer in the world and despite survival rates increasing over the last decade, there remains a requirement...

How to get reproducible DNA amplification

How to get reproducible DNA amplification

Eppendorf for Bioprocess – Solutions that grow with you | 27-Jun-2017 | Infographic

DNA concentration, mastermix preparation, temperature management: Doing PCR like a pro can be more complex than it seems.The Eppendorf infographic helps...

Increase tablet production with multi-tip tools

Increase tablet production with multi-tip tools

I Holland Limited - Tabletting Science | 01-Jun-2017 | Technical / White Paper

Multi-tip punches increase the number of tablets produced per turret rotation, which increases production rates of existing presses.This tooling has transformed...

REC130

Selecting a dosage form for delivery to the lungs

Recipharm AB | 15-May-2017 | Technical / White Paper

Selecting and developing an appropriate dosage form for inhalation products can be challenging. The physicochemical properties of the API, the required...

First-in-Human Development Strategies

First-in-Human Development Strategies

Catalent Pharma Solutions | 01-May-2017 | Insight Guide

Crucial and cost-effective factors to consider when transforming a pre-clinical development compound into a first-in-human, early-phase drug candidate....

Free Infographic: Stem Cell Expansion in Bioreactors

Free Infographic: Stem Cell Expansion in Bioreactors

Eppendorf for Bioprocess – Solutions that grow with you | 28-Mar-2017 | Infographic

To produce large numbers of stem cells in consistent quality, bioreactors offer many advantages over dishes and flasks. However, switching the culture...

Ajinomoto-logo

The Power to Make, A Virtual Tour

Althea | 24-Mar-2017

You have the power to make a difference. To make new therapeutics that improve quality of life and inspire a healthier world. To do this, you need a manufacturing...

RXLR2-page-001

Taking fill release rates to a new level

Gelita AG | 20-Mar-2017 | Technical / White Paper

Various attempts by the pharmaceutical industry to reduce cross-linking with additives have only been partially successful. GELITA, however, followed another...

psi

psiXchange - Innovating SUSAR Distribution

pharmasol | 20-Mar-2017 | Technical / White Paper

A controlled document distribution process, in which getting the right information to the intended recipients within a required time frame and being able...

Serialisation 610 x343 px

Serialisation – know the facts

Recipharm AB | 20-Mar-2017 | Product Presentation

The EU and US deadlines for serialisation are looming and pharmaceutical companies need to be prepared in order to ensure compliance. Implementing serialisation...

VALSYNTHESE – Custom phosgenation under GMP

VALSYNTHESE – Custom phosgenation under GMP

Valsynthese SA | 01-Mar-2017 | Technical / White Paper

Phosgene is a powerful reagent allowing the straightforward synthesis of key intermediates such as chloroformates, acid chlorides, and carbamoyl chlorides....

Producing the perfect soft gel

Producing the perfect soft gel

Leading manufacturer of gelatine and collagen peptides | 17-Jan-2017 | Technical / White Paper

This white paper outlines the key considerations to ensure gelatin is enhanced for soft gel formulation, efficient gel production and optimal API delivery...

Patient-Centric Drug-Development Process

Patient-Centric Drug-Development Process

Catalent Pharma Solutions | 28-Nov-2016 | Insight Guide

For large and small pharmaceutical companies alike; developing a new drug is fraught with risk. Patient-centric drug development and optimization is both...

Choosing the Right Size Sphere

Choosing the Right Size Sphere

Colorcon Inc. | 21-Nov-2016 | Technical / White Paper

Choosing the right size sugar sphere, for a multiparticulate dosage form is imperative.  Size matters; not only to achieve a robust formulation and efficient...

Tailoring the autoinjection with SAFELIA®

Tailoring the autoinjection with SAFELIA®

Nemera | 21-Nov-2016 | Technical / White Paper

For a better patient experience and for an optimized drug deliver, including for high volumes high viscosities formulation.Safelia injection course can...

Experience foam for topical drug delivery

Experience foam for topical drug delivery

Gattefossé | 14-Nov-2016 | Technical / White Paper

Pharmaceutical foams are becoming more popular probably due to more topical medicines being switched to OTC and the need to innovate and differentiate...

Elemental Impurities Regulations View from a CRO

Elemental Impurities Regulations View from a CRO

RSSL | 02-Nov-2016 | Technical / White Paper

Regulatory control of elemental impurities in pharmaceutical products has long been discussed, with both the European Pharmacopeia (EP) and the United...

pH measurement: Six technical tips

pH measurement: Six technical tips

Metrohm – customized analysis for the pharmaceutical industry | 10-Oct-2016 | Technical / White Paper

The pH value is one of the most important and therefore also one of the most frequently measured quantities in analytical chemistry. Sometimes a simple...

The Time for Supply Chain Transformation Has Come

The Time for Supply Chain Transformation Has Come

Catalent Pharma Solutions | 26-Sep-2016 | Insight Guide

Adaptive protocol designs, shrinking trial sizes and a growing focus on patients are just a few of the clinical trial trends and recent innovations that...

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers